News

Extensively studied over decades, fluoride has been scientifically validated for its effectiveness in reducing dental ...
The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...
The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for patients and insurers. The big picture: Blockbuster treatments like Ozempic ...
The FDA has issued a second-highest risk warning for a nationwide recall of mislabeled stevia and monk fruit sweeteners from NuNaturals Inc. Here's what to know.
References FDA grants priority review for Winrevair (sotatercept-csrk) to update label based on results from ZENITH trial. News release. BusinessWire. July 2, 2025.
FDA rejects Genentec's cancer drug label expansion Jul. 18, 2025 2:45 PM ET Roche Holding AG (RHHBY) Stock, RHHBF Stock, RHHVF Stock By: Nilanjana Basu, SA News Editor Play (1min) ...
The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The ...
Incyte (NASDAQ: INCY) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its immunotherapy product Monjuvi as part of a combination regimen for ...
Arizona Republican Gov. Doug Ducey on March 21 signed a bill into law that allows drug and device companies to promote off label uses of their drugs to clinicians, reports The Arizona Republic.